Murine cytomegalovirus inhibits interferon γ-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes

Journal of Experimental Medicine

Volumn 187, Issue 7, 1998, Pages 1037-1046

  Heise, Mark T ^a   Connick, Megan ^a   Virgin IV, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA ACTIN; BETA INTERFERON; CD4 ANTIGEN; CD45 ANTIGEN; CYCLOPHILIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HISTOCYTOCHEMISTRY; INTERFERON TYPE II; MACROPHAGES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, KNOCKOUT; MUROMEGALOVIRUS; RNA, MESSENGER; SALIVARY GLANDS; SIGNAL TRANSDUCTION;

EID: 0032489859     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.7.1037     Document Type: Article

References (60)

1. Lucin, P., I. Pavic, B. Polic, S. Jonjic, and U.H. Koszinowski. 1992. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66:1977-1984.
2. Pavic, I., B. Polic, I. Crnkovic, P. Lucin, S. Jonjic, and U.H. Koszinowski. 1993. Participation of endogenous tumour necrosis factor-alpha in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:2215-2223.
3. Heise, M.T., and H.W. Virgin. 1995. The T-cell-independent role of IFN-gamma and TNF-alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infection. J. Virol. 69:904-909.
4. Orange, J.S., B. Wang, C. Terhorst, and C.A. Biron. 1995. Requirement for natural killer cell-produced interferon-γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1056.
5. Orange, J.S., and C.A. Biron. 1996. Characterization of early IL-12, IFN-alpha/beta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746-4756.
6. Bukowski, J.F., J.F. Warner, G. Dennert, and R.M. Welsh. 1985. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 161:40-52.
7. Tay, C.H., and R.M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267-275.
8. Pollock, J.L., and H.W. Virgin. 1995. Latency, without persistence, of murine cytomegalovirus in spleen and kidney. J. Virol. 69:1762-1768.
9. Reddehase, M.J., W. Mutter, K. Munch, H.J. Buhring, and U.H. Koszinowski. 1987. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J. Virol. 61:3102-3108.
10. +T lymphocytes. J. Virol. 64:5457-5464.
11. + T lymphocytes. J. Exp. Med. 169:1199-1212.
12. Del Val, M., H. Hengel, H. Hacker, U. Hartlaub, T. Ruppert, P. Lucin, and U.H. Koszinowski. 1992. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 176: 729-738.
13. Jones, T.R., L.K. Hanson, L. Sun, J.S. Slater, R.M. Stenberg, and A.E. Campbell. 1995. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:4830-4841.
14. Wiertz, E.J., T.R. Jones, L. Sun, M. Bogyo, H.J. Geuze, and H.L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84:769-79.
15. Slater, J.S., and A.E. Campbell. 1997. Down-regulation of MHC class I synthesis by murine cytomegalovirus occurs in immortalized but not primary fibroblasts. Virology. 229:221-227.
16. Ahn, K., G. Gruhler, B. Galocha, T.R. Jones, E.J. Wiertz, H.L. Ploegh, P.A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 6:613-621.
17. Farrell, H.E., H. Vally, D.M. Lynch, P. Fleming, G.R. Shellam, A.A. Scalzo, and N.J. Davis-Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homolog in vivo. Nature. 386:510-514.
18. Reyburn, H.T., O. Mandelboim, M. Vales-Gomez, D.M. Davis, E. Pazmany, and J.E. Strominger. 1997. The class I homolog of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:514-517.
19. Slater, J.S., W.S. Futch, V.J. Cavanaugh, and A.E. Campbell. 1991. Murine cytomegalovirus independently inhibits priming of helper and cytotoxic T lymphocytes. Virology. 185: 132-139.
20. Sedmak, D.D., S. Chaiwiriyakul, D.A. Knight, and W.J. Waldmann. 1995. The role of interferon β in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells. Arch. Virol. 140:111-126.
21. Sedmak, D.D., A.M. Guglielmo, D.A. Knight, D.J. Birmingham, E.H. Huang, and W.J. Waldman. 1994. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am. J. Pathol. 144:683-692.
22. Fish, K.N., W. Britt, and J.A. Nelson. 1996. A novel mechanism for persistence of human cytomegalovirus in macrophages. J. Virol. 70:1855-1862.
23. Heise, M.T., J.L. Pollock, S.K. Bromley, M.L. Barkon, and H.W. Virgin. 1998. Murine cytomegalovirus infection suppresses interferon-gamma-mediated MHC class II expression on macrophages: the role of type I interferon. Virology. In Press.
24. Katzenstein, D.A., G.S. Yu, and M.C. Jordan. 1983. Lethal infection with murine cytomegalovirus after early viral replication in the spleen. J. Infect. Dis. 148:406-411.
25. Stoddart, C.A., R.D. Cardin, J.M. Boname, W.C. Manning, G.B. Abenes, and E.S. Mocarski. 1994. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68:6243-6253.
26. Collins, T.M., M.R. Quirk, and M.C. Jordan. 1994. Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J. Virol. 68:6305-6311.
27. Saltzman, R.L., M.R. Quirk, and M.C. Jordan. 1988. Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J. Clin. Invest. 81: 75-81.
28. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597-1604.
29. Kondo, K., H. Kaneshima, and E.S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA. 91:11879-11883.
30. Pollock, J.L., R.M. Presti, S. Paetzold, and H.W. Virgin. 1997. Latent murine cytomegalovirus infection in macrophages. Virology. 227:168-179.
31. Soderberg-Naucler, C., K.N. Fish, and J.A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell. 91: 119-126.
32. Muller, U., S. Steinhoff, L.F.L. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264: 1918-1921.
33. Stabell, E.C., and P.D. Olivo. 1992. Isolation of a cell line for rapid and sensitive histochemical assay for the detection of herpes simplex virus. J. Virol. Methods. 38:195-204.
34. Greenlund, A.C., M.A. Farrar, B.L. Viviano, and R.D. Schreiber. 1994. Ligand-induced IFN-gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO (Eur. Mol. Biol. Organ.) J. 13:1591-1600.
35. Cohen, B., D. Peretz, D. Vaiman, P. Benech, and J. Chebath. 1988. Enhancer-like interferon responsive sequences of the human and murine (2′-5′) oligoadenylate synthetase gene promoters. EMBO (Eur. Mol. Biol. Organ.) J. 7:1411-1419.
36. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Gold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 7.43-7.50.
37. Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Related expression of a gene encoding a nuclear factor, IKF-1, that specifically binds to IFN-beta gene regulatory elements. Cell. 54:903-913.
38. Danielson, P.E., S. Forss-Petter, M.A. Brow, L. Calavetta, J. Douglass, R.J. Milner, and J.G. Sutcliffe. 1988. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA (N.Y.). 7:261-267.
39. Marusina, K., M. Iyer, and J.J. Monaco. 1997. Allelic variation in the mouse Tap-1 and Tap-2 transporter genes. J. Immunol. 158:5251-5256.
40. Attaya, M., S. Jameson, C.K. Martinez, E. Hermel, C. Aldrich, J. Forman, K.F. Lindahl, M.J. Bevan, and J.J. Monaco. 1992. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature. 355:647-649.
41. Cho, S., M. Attaya, M.G. Brown, and J.J. Monaco. 1991. A cluster of transcribed sequences between the Pb and Ob genes of the murine major histocompatibility complex. Proc. Natl. Acad. Sci. USA. 88:5197-5201.
42. Strelow, L.I., and D.A. Leib. 1995. Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis. J. Virol. 69:6779-6786.
43. Evavold, B.D., S.G. Williams, B.L. Hsu, S. Buus, and P.M. Allen. 1992. Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J. Immunol. 148:347-353.
44. MacDonald, M.R., X.-Y. Li, and H.W. Virgin. 1997. Late expression of a β chemokine homolog by murine cytomegalovirus. J. Virol. 71:1671-1678.
45. Ting, J.P.-Y., and A.S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8-16.
46. Viville, S., J. Neefjes, V. Lotteau, A. Dierich, M. Lemeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell. 72:635-648.
47. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699-1712.
48. Meraz, M.A., J.M. White, K.C.F. Sheehan, E.A. Bach, S.J. Rodig, A.S. Dighe, D.H. Kaplan, J.K. Riley, A.C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat 1 gene in mice reveals unexpected physiologic specificity of the JAK-STAT signalling pathway. Cell. 84:431-442.
49. Pine, R., A. Canova, and C. Schindler. 1994. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN-alpha and IFN-gamma, and likely to autoregulate the p91 gene. EMBO (Eur. Mol. Biol. Organ.) J. 13:158-167.
50. Martin, W.D., G.G. Hicks, S.K. Mendiratta, H.I. Leva, H.E. Ruley, and K.L. Van. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell. 84:543-550.
51. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell. 84:531-541.
52. Fung-Leung, W.P., C.D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P.A. Peterson, S.R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science. 271:1278-1281.
53. Walter, E.A., P.D. Greenberg, M.J. Gilbert, R.J. Finch, K.S. Watanabe, E.D. Thomas, and S.R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
54. Lucin, P., S. Jonjic, M. Messerle, B. Polic, H. Hengel, and U.H. Koszinowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumor necrosis factor. J. Gen. Virol. 75: 101-110.
55. Gribaudo, G., S. Ravaglia, A. Caliendo. R. Cavallo, M. Gariglio, M.G. Martinotti, and S. Landolfo. 1993. Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology. 197:303-311.
56. Bhattacharya, S., R. Eckner, S. Grossman, E. Oldread, Z. Arany, A. D'Andrea, and D.M. Livingston. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature. 383:344-347.
57. Chang, C.-H., S. Guerder, S.-C. Hong, W. van Ewijk, and R.A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment ot MHC class II expression. Immunity. 4:167-178.
58. Chin, K.C., C. Mao, C. Skinner, J.L. Riley, K.L. Wright, C.S. Moreno, G.R. Stark, J.M. Boss, and J.P. Ting. 1994. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity. 1:687-697.
59. Steimle, V., C.A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 265:106-109.
60. Kern, I., V. Steimle, C.A. Siegrist, and B. Mach. 1995. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7: 1295-1299.